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Abstract
Background:To conduct a systematic review to answer the clinical question “What are the effectiveness of mandibular distraction
osteogenesis (MDO) and its complications to treat patients with obstructive sleep apnea syndrome (OSAS)?”.
Methods:A systematic search including a computer search with speciﬁc keywords, reference list search, and manual search were
done. Relevant articles on MDO were assessed and selected in 3 rounds for ﬁnal review based on 5 predeﬁned inclusion criteria and
followed by a round of critical appraisal. Different types of distraction and their treatment outcomes of OSAS were recorded with
standardized form and analyzed.
Results: Twelve articles were included in the ﬁnal review. A total of 256 patients aged 7 days to 60 years were treated with either
external or internal MDO, with a mean follow-up period of 6 to 37 months. The average distraction distance of 12 to 29mm was
achieved with various distraction protocols. The success rate for adult patients was 100%, and cure rates were ranged from 82% to
100%. The deﬁnition of success or cure for OSAS in children or infants was not deﬁned. Therefore, there were no clearly reported
success or cure rates for children/infants in the included studies. However, all studies reported that these patients showed signiﬁcant
improvement in OSAS, with many of them who avoided tracheostomy or had the tracheostomy decannulated. The complication
rates were ranged from 0% to 21.4%, with most being from local wound infections or neurosensory disturbances.
Conclusion: This systematic review showed that MDO was effective in resolving OSAS in adults with retrognathic mandible. MDO
also showed promising results in infants or children with OSAS. From the results of this systematic review, we recommend to deﬁne
the criteria of success or cure for OSAS surgery in children and infants. We also recommend setting up randomized controlled trials to
compare MDO with traditional maxillomandibular advancement surgery for OSAS patients and to provide a better evidence on the
success and complication rates of the techniques.
Abbreviations: AASM = American Academy of Sleep Medicine, AHI = apnea–hypopnea index, BMDO = bilateral mandibular
distraction osteogenesis, BSSO = bilateral sagittal split osteotomies, CPAP = continuous negative airway pressure, LF-I = Le-Fort I,
MDO = mandibular distraction osteogenesis, MMA = maxillomandibular advancement, OSA = obstructive sleep apnea, OSAS =
obstructive sleep apnea syndrome, PAS= posterior airway space, PRISMA= Preferred Reporting Items for Systematic Reviews and
Meta-Analyses, PSG = polysomnography.
Keywords: complications, distraction osteogenesis, obstructive sleep apnea, success rate
1. Introduction description by Guilleminault et al[1]. It has been demonstrated to
lead to cardiovascular- and cerebrovascular-related morbiditiesObstructive sleep apnea syndrome (OSAS) has been a great
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1and mortalities.[2] OSAS is characterized by repeated episodes of
pharyngeal collapse with increased resistance of airﬂow during
sleep and daytime somnolence,[1] and is a debilitating and
potentially lethal condition. The prevalence of OSAS in Hong
Kong was found to be 4.1% in the middle-aged Chinese male.[3]
However, it is believed there is a large pool of undiagnosed OSAS
in the community, and particularly in the patients with
hypertension, with the prevalence that may reach about 17%.[4]
Treatments for obstructive sleep apnea (OSA) are mainly
categorized into medical or surgical. The current gold standard
medical treatment is by continuous negative airway pressure
(CPAP) and it is still the mainstay treatment strategy for a large
proportion of patients with OSAS. The Cochrane systematic
review concluded that CPAP is effective in reducing symptoms of
sleepiness and improving the quality of life measures in patients
with moderate and severe OSA.[5] However, the compliance to
CPAP has long been reported to be poor, with the reported
tolerance rates to be as poor as less than 50%.[6,7] Its less-than-
satisfactory long-term compliance is commonly related to
Tsui et al. Medicine (2016) 95:36 Medicinetolerance problems and psychological issues, such as disturban-
ces to the sleeping partners and sexual life.[8]
Surgical treatment is another scope of management for OSAS
and provides a possibility for permanent cure. Surgical
procedures on soft and hard tissue have been performed to
increase the posterior airway space (PAS). Uvulopalatophar-
yngoplasty and tongue base reduction are the commonly
performed soft tissue surgeries for OSAS.[9–11] However, they
are known to cause signiﬁcant postoperative pain, and their
reported success rates were only around 40% to 60%.[12–14]
Clinical studies showed that the airway obstruction of OSAS
usually occurred at multiple levels rather than localized at one
single region along the upper airway.[15–19] In a recent
systematic review, it is shown that maxillomandibular
advancement (MMA) surgery was safe and highly effective
for treating OSAS patients, with promising results in the
apnea–hypopnea index (AHI) reduction.[20] It was concluded
that MMA could enlarge the airways 3 dimensionally
by expanding the whole skeletal framework. As a result, the
pharyngeal soft tissues and tongue would be more resistant
to collapse during inspiration. MMA might also maintain or
even improve the dental occlusion and thus the masticatory
function.
It is understood that MMA by means of conventional
orthognathic surgery has its inherent drawbacks. It has been
associated with a high incidence of neurosensory deﬁcits and
postsurgical relapse.[21–26] The amount of advancement is limited
by the method of ﬁxation and its potential instability.[21,25]
Although conventional orthognathic surgery can achieve imme-
diate result, the relapse rate is high when the amount of
advancement is signiﬁcant, especially in syndromic patients and
those with severe retrognathic mandible. In 1992, McCarthy
et al[27] ﬁrst applied distraction osteogenesis on facial bone to
generate new bone when osteotomized bony segments undergo
controlled separation in small increments with a mechanical
device. Distraction osteogenesis allows incremental traction to
the reparative callus that initiates a sequence of adaptive changes
in the soft tissue. It was therefore hypothesized that distraction
osteogenesis might allow larger skeletal movement while
reducing the potential for skeletal relapse and neurosensory
deﬁcit.[28,29] The technique has been shown to lengthen severely
retrognathic mandibles successfully beyond the limits of
conventional orthognathic surgery.[27,30–33] In OSAS cases, the
potential beneﬁts of mandibular distraction osteogenesis (MDO)
are enlargement of the upper airway to improve oxygen
saturation and respiratory disturbance index. In pediatric
syndromic cases with OSAS, the technique may also accelerate
the growth of affected infants and children in terms of weight gain
when compared to patients without early intervention with
MDO.[34] However, MDO was reported to carry potential
morbidities, which include transient hypoesthesia of the inferior
alveolar nerve, local wound infection, pin tract infection,
mechanical failure such as pin loosening and distractor breakage,
and hypertrophic scarring particularly due to the use of external
distractors.[35–37] A second operation is needed to remove the
distractors after the consolidation period of the distraction
process.
To justify the use of MDO to treat OSAS, it is important to
know the effectiveness of this treatment modality and its potential
morbidities. Individual study onMDO to treat OSAS was limited
by the small sample size and the speciﬁc patient group the study
was reporting. The aim of this study was therefore to conduct a
systematic review to answer a clinical question “What are the2effectiveness of MDO and its complications to treat patients with
OSAS?”.
2. Materials and methods
2.1. Search strategy
In order to provide the best available evidence on the effectiveness
of MDO on the treatment of OSAS, we performed a systematic
review according to the PRISMA statement.[38] Three rounds of
search and evaluation were carried out and then followed by 1
round of critical appraisal.
2.1.1. First round search.We systematically identiﬁed relevant
publications by searching the electronic databases of PubMed,
Ovid, Scopus, and the Cochrane Library. The following key
terms and their combinations were used:1.
2.Distraction
Distraction osteogenesis3. Sleep apnea
4. Airway obstruction.The electronic search was updated to August 12, 2014. No
restrictions on publication date, language, or status of publica-
tion were imposed. The abstracts of the articles from the
computer search were reviewed. When the information was
insufﬁcient or the abstracts were not available, the full articles
were retrieved and reviewed. Full texts of potentially eligible
studies relevant to the treatment of OSA by MDO were obtained
and included in the second round.
2.1.2. Second round search.We also performedmanual search
in 3 relevant international journals including the International
Journal of Oral and Maxillofacial Surgery, the Journal of Oral
and Maxillofacial Surgery, and the Plastic and Reconstructive
Surgery. The hand search of these journals was limited to the
publication period from January 2000 to August 2014. Articles
relevant to the treatment of OSA by MDO were selected. In
addition, reference lists of all the included studies from the
manual search and the ﬁrst round were manually searched.
Articles relevant to the treatment of OSA byMDOwere selected.
All the selected articles in the second round searches were put in
the third round evaluation.
2.1.3. Third round evaluation. Evaluation of the selected
articles from the second round was performed according to
the following inclusion criteria:1. Clinical trial or case series reporting on the treatment outcome
of OSA with MDO
Human studies2.
3. The treatment provided clearly described
4. The preoperative and postoperative AHI or respiratorydisturbance index (RDI) were reported
The duration of the follow-up period of the subjects was5.
reported.
A standardized evaluation form was used for critical
evaluation of the included studies. The reasons for exclusion
of a study were also recorded. Studies were considered eligible for
the ﬁnal round of critical appraisal if they fulﬁlled all 5 predeﬁned
inclusion criteria mentioned above.
2.1.4. Critical appraisal of studies. Two independent assessors
critically appraised the studies selected from the third round on
the following 4 aspects. When there was any discrepancy during
Tsui et al. Medicine (2016) 95:36 www.md-journal.comthe appraisal process between the 2 reviewers, consensus was
reached with discussion.
2.1.5. Sample size/study design. If the study was a case series,
the sample size should be more than 10 subjects. While the study
was a randomized controlled trial, the randomization process
needed to be clearly reported.
2.1.6. Description of treatment methods and distraction
protocol. The indication for MDO should be described. The
types of distractors used and the period of activation period
should be reported. The length of latency and consolidation has
to be mentioned with details.
2.1.7. Description of outcome variables. In order to compare
the treatment outcomes between studies, the preoperative and
postoperative polysomnography (PSG) AHI/RDI should be
clearly reported. The number of cases requiring tracheostomy
and the number of patients who could be decannulated after the
surgery should be clearly stated.
2.1.8. Clinical follow-up. Clinical follow-up periods must be
mentioned in the studies, and the duration should be at least 6
months. If there was any dropout during the study period, it
should be reported and explained in detail. All studies
fulﬁlling all of the above standards would be included in the
ﬁnal review.2.2. Data extraction
Data were extracted using a standard data extraction sheet that
was speciﬁcally designed for this review. Various details of the
included studies were extracted and analyzed: source of sample,
sample size and their nature, mode of distraction, protocol of
distraction, amount of distraction, treatment outcomes, duration
of follow-up period, and complications.
2.3. Ethical approval
Ethical approval was not necessary as this study was a systematic
review of the literature.
3. Results
A total of 534 studies were identiﬁed using the predeﬁned
keywords, of which 259 studies were generated from PubMed, 94
studies from Ovid, 181 studies from Scopus, and none from the
Cochrane Library. The abstracts of these studies from the ﬁrst
round search were reviewed. Of these, 435 studies were found to
be irrelevant. Ninety-eight studies were found to be relevant to
the treatment of OSAwithMDO andwere included in the second
round.[34,39–134]
No extra studies were identiﬁed through the manual search of
the 3 international journals (Journal of Oral and Maxillofacial
Surgery, International Journal of Oral and Maxillofacial
Surgery, and Plastic and Reconstructive Surgery) from the
period of January 2000 to August 2014. There were also no
articles related to the treatment of OSA with MDO identiﬁed
further from the reference lists search of the included studies in
the ﬁrst round. Full texts of all these 97 studies were retrieved
for the third round evaluation according to the 5 inclusion
criteria.
Eighty-ﬁve studies failed 1 or more of the 5 predeﬁned
inclusion criteria and were excluded in the third round. The
articles excluded in the third round and the reasons for3exclusion were shown in Table 1. Twelve articles fulﬁlled the 5
criteria and entered the ﬁnal round of critical
appraisal.[45,64,75,77,79,85,87,95,96,100,101,124] All the 12 articles
passed the appraisal and were included in the ﬁnal review. The
study selection process was shown in ﬂow diagram in Fig. 1.
The articles in the ﬁnal review were shown in Table 2. The
results from the studies were shown in Table 3a and b.
All 12 studies were retrospective case series and were published
in English. There was no systematic review, meta-analysis, or
randomized controlled trials identiﬁed. Nine studies reported
treatments on children or infants, and 8 of them were on
syndromic patients. Three studies reported on adults and all of
them were having either unilateral or bilateral temporomandib-
ular joint ankylosis with associated retrognathic mandible and
OSA.
A total of 256 patients aged between 7 days to 60 years with
OSA due to retrognathic mandible were treated with MDO. No
studies reported the pre- and postoperative body mass index.
Internal distractors were used in most of the studies placed using
intraoral approach in adults or extraoral approach in children or
infants due to limited access transorally. All except 1 study used
curvilinear distractors for distraction of both ramus and
mandibular body at the same time,[75] while others use single
vector distractors in their cases. One study reported the use of
resorbable internal distractors in which only the distraction
screwswere removed after the completion of distraction.[124] The
mandibular advancement achieved was 12 to 29mm. Seven
studies mentioned the need for postoperative monitoring or
delayed extubation in the intensive care unit for several days
(1–11.4 days) until the postsurgical swelling subsided or until the
desired amount of distraction was achieved.[64,75,77,79,87,101,124]
The mean reported follow-up period ranged from 6 to 37
months.3.1. Preoperative and postoperative assessments
All 12 studies used PSG for diagnosis of OSA and for
postoperative assessment of improvement of sleep apnea after
MDO. Majority of studies used lateral cephalometric radio-
graphs or CT scan for surgical planning as well as assessment of
airway dimension both pre- and postoperatively. Endoscopy was
commonly employed for assessment of airway dimension and to
identify any pathology along the airway. Swallowing and feeding
assessment was also performed in children and infants, especially
in the syndromic populations in which esophageal regurgitation
was a common ﬁnding. Three-dimensional stereo-models were
also used for surgical planning in terms of distraction vectors and
amount of advancement required in relation to the maxilla or
skeletal proﬁle.3.2. Distraction protocols
The protocol for distraction varies among different studies within
a small range. The latency period ranged from 1 to 7 days.
Children or infants were usually allowed for a shorter latency
period of 1 to 5 days, while adult patients were allowed for 5 to 7
days. The protocol of distraction also varied among studies,
ranging from 0.8 to 2mm per day in 1 to 4 rhythms. The
consolidation period varied from 4 to 28.9 weeks, while the
majority was in the range of 2 to 4 months. All but 1 study
reported removal of distractors under local anesthesia or
sedation, while others were all performed under general
anesthesia, after the consolidation period was completed. Six
Table 1
Studies excluded at the third round.
References Title Reasons for exclusion
1. Mudd et al[34] Early intervention: distraction osteogenesis of the mandible for severe airway obstruction Insufﬁcient PSG/follow-up data
2. Pluijmers et al[39] Custom-made intraoral mandibular distraction as treatment for neonatal airway obstruction Sample size less than 10
Insufﬁcient PSG/follow-up data
3. Hong et al[40] Feeding and mandibular distraction osteogenesis in children with Pierre Robin sequence: a
case series of functional outcomes
Sample size less than 10
Insufﬁcient PSG/follow-up data
4. Ahmad et al[41] Frontofacial monobloc distraction in the very young: a review of 12 consecutive cases Not treatment outcome of MDO
Insufﬁcient PSG/follow-up data
5. Hong et al[42] Mandibular distraction osteogenesis in children with Pierre Robin sequence: impact on
health-related quality of life
Not treatment outcome of MDO
Insufﬁcient PSG/follow-up data
6. Handley et al[43] Predicting surgical intervention for airway obstruction in micrognathic infants Not treatment outcome of MDO
7. Andrews et al[44] Incidence of concomitant airway anomalies when using the university of California, Los
Angeles, protocol for neonatal mandibular distraction
Not clinical trials/case series
Not treatment outcome of MDO
8. Morovic and Monasterio[46] Distraction osteogenesis for obstructive apneas in patients with congenital craniofacial
malformations
Not clinical trials/case series
Sample size less than 10
Insufﬁcient PSG/follow-up data
9. Li et al[47] Skeletal expansion by gradual intraoral distraction osteogenesis for the treatment of
obstructive sleep apnea
Not clinical trials/case series
10. Wu et al[48] Mandibular distraction osteogenesis for improving respiratory function in patients with
micrognathia complicated by obstructive sleep apnea syndrome
Sample size less than 10
Insufﬁcient PSG/follow-up data
11. Steinberg and Fattahi[49] Distraction osteogenesis in management of pediatric airway: evidence to support
its use
Not clinical trials/case series
12. Li[50] Distraction osteogenesis and obstructive sleep apnea syndrome Not clinical trials/case series
13. Cohen et al[51] Surgical treatment of obstructive sleep apnea in neurologically compromised patients Insufﬁcient PSG/follow-up data
14. Chin and Toth[52] Le Fort III advancement with gradual distraction using internal devices Not treatment outcome of MDO
Sample size less than 10
Insufﬁcient PSG/follow-up data
15. Cohen et al[53] Mandibular distraction osteogenesis in the treatment of upper airway obstruction in children
with craniofacial deformities
Insufﬁcient PSG/follow-up data
16. Cohen et al[54] Skeletal expansion combined with soft-tissue reduction in the treatment of obstructive sleep
apnea in children: physiologic results
Not treatment outcome of MDO
Insufﬁcient PSG/follow-up data
17. Cedars et al[55] Advancement of the midface using distraction techniques Not treatment outcome of MDO
Insufﬁcient PSG/follow-up data
18. Fearon[56] The Le Fort III osteotomy: to distract or not to distract? Not treatment outcome of MDO
Insufﬁcient PSG/follow-up data
19. Denny et al[57] Mandibular distraction osteogenesis in very young patients to correct airway obstruction Insufﬁcient PSG/follow-up data
20. Wang et al[58] [Distraction osteogenesis in correction of mandibular micrognathia accompanying obstructive
sleep apnea syndrome]
Insufﬁcient details on methods
21. Li et al[59] Distraction osteogenesis in adult obstructive sleep apnea surgery: a preliminary report Sample size less than 10
22. Tang et al[60] [Management of micrognathia deformity associated with obstructive sleep apnea syndrome
by distraction osteogenesis]
Sample size less than 10
Insufﬁcient PSG/follow-up data
23. Monasterio et al[61] Distraction osteogenesis in Pierre Robin sequence and related respiratory problems in
children
Insufﬁcient PSG/follow-up data
24. Izadi et al[62] Correction of upper airway obstruction in the newborn with internal mandibular distraction
osteogenesis
Insufﬁcient PSG/follow-up data
25. Lu et al[63] [Treatment of distraction osteogenesis in the patients of obstructive sleep apnea–hypopnea
syndrome with micrognathia]
Insufﬁcient or no information on methods
26. Mandell et al[65] Mandibular distraction for micrognathia and severe upper airway obstruction Insufﬁcient PSG/follow-up data
27. Guilleminault and Li[66] Maxillomandibular expansion for the treatment of sleep-disordered breathing: preliminary
result
Not treatment outcome of MDO
Sample size less than 10
28. Wittenborn et al[67] Neonatal distraction surgery for micrognathia reduces obstructive apnea and the need for
tracheotomy
Insufﬁcient PSG/follow-up data
29. Fearon[68] Halo distraction of the Le Fort III in syndromic craniosynostosis: a long-term assessment Not treatment outcome of MDO
(continued )
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References Title Reasons for exclusion
30. Zhou et al[69] [Orthognathic surgery and distraction osteogenesis for treatment of obstructive sleep apnea
hypopnea syndrome]
Insufﬁcient PSG/follow-up data
31. Steinbacher et al[70] Mandibular advancement by distraction osteogenesis for tracheostomy-dependent children
with severe micrognathia
Sample size less than 10
Insufﬁcient PSG/follow-up data
32. Teng et al[71] [Mandibular distraction osteogenesis in the treatment of obstructive sleep apnea syndrome
in children with micrognathia]
Sample size less than 10
Insufﬁcient PSG/follow-up data
33. Lu[72] [Orthognathic surgery and distraction osteogenesis for the treatment of OSAHS] Sample size less than 10
Insufﬁcient or no information on methods
Insufﬁcient PSG/follow-up data
34. Lin et al[73] Relief of upper airway obstruction with mandibular distraction surgery: long-term
quantitative results in young children
Sample size less than 10
Insufﬁcient or no information on methods
35. Liang et al[74] [Clinical study of simultaneous correction of unilateral temporomandibular joint ankylosis
and mandibular micrognathia with internal distraction osteogenesis]
Sample size less than 10
36. Flores et al[76] Airway changes following Le Fort III distraction osteogenesis for syndromic craniosynostosis:
a clinical and cephalometric study
Not treatment outcome of MDO
Insufﬁcient PSG/follow-up data
37. Mahrous Mohamed et al[78] Distraction osteogenesis as followed by CT scan in Pierre Robin sequence Insufﬁcient PSG/follow-up data
38. Sadakah et al[80] Bilateral intra-oral distraction osteogenesis for the management of severe congenital
mandibular hypoplasia in early childhood
Sample size less than 10
39. Miloro[81] Mandibular distraction osteogenesis for pediatric airway management Insufﬁcient PSG/follow-up data
40. Nout et al[82] Upper airway changes in syndromic craniosynostosis patients following midface or
monobloc advancement: correlation between volume changes and respiratory outcome
Not treatment outcome of MDO
41. Fu et al[83] [Application of distraction osteogenesis in the treatment of severe mandibular micrognathia
with severe obstructive sleep apnea and hypopnea syndrome]
Insufﬁcient PSG/follow-up data
42. Rachmiel et al[84] Distraction osteogenesis for tracheostomy dependent children with severe micrognathia Insufﬁcient PSG/follow-up data
43. Mitsukawa et al[86] Early midfacial distraction for syndromic craniosynostotic patients with obstructive sleep
apnoea
Not treatment outcome of MDO
44. Daniel et al[88] Airway, feeding and growth in infants with Robin sequence and sleep apnoea Sample size less than 10
Insufﬁcient or no information on methods
Insufﬁcient PSG/follow-up data
45. Schoemann et al[89] Immediate mandibular distraction in mandibular hypoplasia and upper airway obstruction Insufﬁcient PSG/follow-up data
46. Abramson et al[90] Effects of mandibular distraction osteogenesis on three-dimensional airway anatomy in
children with congenital micrognathia
Not clinical trials/case series
Insufﬁcient PSG/follow-up data
47. Cheng et al[91] Distraction osteogenesis and glossopexy for Robin sequence with airway obstruction Sample size less than 10
48. Brevi et al[92] Use of the mandibular distraction technique to treat obstructive sleep apnea syndrome Sample size less than 10
49. Ettinger et al[93] Quantitative computed tomographic scan and polysomnographic analysis of patients with
syndromic midface hypoplasia before and after Le Fort III distraction advancement
Not treatment outcome of MDO
50. Mitsukawa and Satoh[94] Midfacial distraction using a transfacial pinning technique for syndromic craniosynostosis
with obstructive respiratory disorders
Not treatment outcome of MDO
Sample size less than 10
51. Nelson et al[97] Effect of midfacial distraction on the obstructed airway in patients with syndromic bilateral
coronal synostosis
Not treatment outcome of MDO
52. Yi et al[98] [Treatment of severe micrognathia accompanying obstructive sleep apnea hypopnea
syndrome with rigid external distractor]
Not treatment outcome of MDO
Sample size less than 10
Insufﬁcient PSG/follow-up data
53. Zhou et al[99] [Upper airway morphologic changes in obstructive sleep apnea hypopnea syndrome patients
before and after orthognathic surgery and distraction osteogenesis]
Not treatment outcome of MDO
Insufﬁcient or no information on methods
54. Monasterio et al[102] Swallowing disorders in Pierre Robin sequence: its correction by distraction Insufﬁcient PSG/follow-up data
55. Sesenna et al[103] Mandibular distraction in neonates: indications, technique, results Insufﬁcient PSG/follow-up data
56. Breugem et al[104] Bioresorbable distraction device for the treatment of airway problems for infants with Robin
sequence
Insufﬁcient PSG/follow-up data
57. Scott et al[105] Mandibular distraction osteogenesis in infants younger than 3 months Insufﬁcient PSG/follow-up data
58. Baciliero et al[106] Respiratory distress in Pierre Robin sequence: an experience with mandible traction by
wires
Not treatment outcome of MDO
(continued )
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References Title Reasons for exclusion
59. Olson et al[107] Endoscopic changes in the upper airway after mandibular distraction osteogenesis Not treatment outcome of MDO
Insufﬁcient PSG/follow-up data
60. Tibesar et al[108] Distraction osteogenesis of the mandible for airway obstruction in children: long-term
results
Insufﬁcient PSG/follow-up data
61. Franco et al[109] Mandibular distraction using bone morphogenic protein and rapid distraction in neonates
with Pierre Robin syndrome
Sample size less than 10
62. Gozu et al[110] Airway management in neonates with Pierre Robin sequence Insufﬁcient or no information on methods
Insufﬁcient PSG/follow-up data
63. Shen et al[111] [Treatment of airway obstruction with mandibular distraction osteogenesis in Pierre Robin
syndrome]
Sample size less than 10
64. Brooker and Cooper[112] Airway management for infants with severe micrognathia having mandibular distraction
osteogenesis
Sample size less than 10
Insufﬁcient PSG/follow-up data
65. Senders et al[113] Mandibular distraction osteogenesis used to treat upper airway obstruction Insufﬁcient PSG/follow-up data
66. Shen et al[114] Mandibular distraction osteogenesis to relieve Pierre Robin severe airway obstruction in
neonates: indication and operation
Sample size less than 10
Insufﬁcient PSG/follow-up data
67. Pradel et al[115] Mandibular traction—an alternative treatment in infants with Pierre Robin sequence Not treatment outcome of MDO
Insufﬁcient or no information on methods
Insufﬁcient PSG/follow-up data
68. Roy et al[116] CT analysis after distraction osteogenesis in Pierre Robin Sequence Not treatment outcome of MDO
Sample size less than 10
Insufﬁcient PSG/follow-up data
69. Lee and Kim[117] Temporary tongue-lip traction during the initial period of mandibular distraction in Pierre
Robin sequence
Sample size less than 10
70. Xu et al[118] [Experience of midfacial distraction osteogenesis in upper airway stenosis] Not treatment outcome of MDO
71. Dauria and Marsh[119] Mandibular distraction osteogenesis for Pierre Robin sequence: what percentage of
neonates need it?
Sample size less than 10
72. Witherow et al[120] Functional outcomes in monobloc advancement by distraction using the rigid external
distractor device
Not treatment outcome of MDO
Insufﬁcient PSG/follow-up data
73. Mathijssen et al[121] Respiratory outcome of mid-face advancement with distraction: a comparison between Le
Fort III and frontofacial monobloc
Not treatment outcome of MDO
Insufﬁcient PSG/follow-up data
74. Spring and Mount[122] Pediatric feeding disorder and growth decline following mandibular distraction osteogenesis Insufﬁcient PSG/follow-up data
75. Denny and Amm[123] New technique for airway correction in neonates with severe Pierre Robin sequence Insufﬁcient PSG/follow-up data
76. Sorin et al[125] Predicting decannulation outcomes after distraction osteogenesis for syndromic
micrognathia
Insufﬁcient or no information on methods
Insufﬁcient PSG/follow-up data
77. Preciado et al[126] Mandibular distraction to relieve airway obstruction in children with cerebral palsy Sample size less than 10
Insufﬁcient PSG/follow-up data
78. Chigurupati et al[127] Internal mandibular distraction to relieve airway obstruction in infants and young children
with micrognathia
Sample size less than 10
Insufﬁcient PSG/follow-up data
79. Holmes et al[128] LeFort III internal distraction in syndromic craniosynostosis Not treatment outcome of MDO
Sample size less than 10
Insufﬁcient PSG/follow-up data
80. Perlyn et al[129] Effect of distraction osteogenesis of the mandible on upper airway volume and resistance in
children with micrognathia
Sample size less than 10
81. Denny and Kalantarian[130] Mandibular distraction in neonates: a strategy to avoid tracheostomy Sample size less than 10
Insufﬁcient PSG/follow-up data
82. Imola et al[131] The versatility of distraction osteogenesis in craniofacial surgery Insufﬁcient PSG/follow-up data
83. Sidman et al[132] Distraction osteogenesis of the mandible for airway obstruction in children Insufﬁcient PSG/follow-up data
84. Lo and Chen[133] Airway obstruction in severe syndromic craniosynostosis Not treatment outcome of MDO
Sample size less than 10
Insufﬁcient PSG/follow-up data
85. Carls and Sailer[134] Seven years clinical experience with mandibular distraction in children Insufﬁcient PSG/follow-up data
MDO=mandibular distraction osteogenesis, PSG=polysomnography.
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Figure 1. Flow diagram for article selection.
Tsui et al. Medicine (2016) 95:36 www.md-journal.comstudies reported overcorrection of 2 to 3mm or until a Class III
skeletal relationship was achieved.3.3. Criteria of success and cure
The criteria of surgical success and cure for adult patients were
well deﬁned in the literature and were stated clearly in the
American Academy of Sleep Medicine (AASM) guideline.[135]
Similar to other review of surgery for OSA,[12,14] the criteria of
success was deﬁned as AHI (or RDI) <20/h and a ≥50% in AHI
(or RDI) postsurgically.[136] The criteria of cure was deﬁned as
AHI (or RDI) <5/h.[137]
However, there were no standard criteria of success or cure for
child or infant group of patients being reported so far. The most
commonly applied criteria in the literature for this group of
patients were disappearance of OSA symptoms, the avoidance of
tracheostomy, or the ability to achieve decannulation postsurgi-
cally, while some studies used the criteria as in the adult group.73.4. Success rate and cure rate
The success rate for the adult group was 100%, while the cure
rate was from 82% to 100% according to the standard AASM
guideline. In the child/infant group, only 4 studies reported their
criteria of success. For the other 5 studies without predeﬁned
criteria, we applied the commonly used criteria (disappearance of
OSA symptoms, the avoidance of tracheostomy, or the ability to
achieve decannulation). The overall success rate ranged from
90% to 100%.
3.5. Respiratory outcomes
All 12 studies reported signiﬁcant improvement of AHI/RDI.
In the adult group, the mean AHI/RDI changed from 51.7/
h (43.0–58.0/h) preoperatively to 2.9/h (2.1–3.4/h) postoper-
atively. In the child/infant group, the mean preoperative
AHI/RDI ranged from 10 to 50/h and was reduced to 1.1 to
5/h.
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Table 3
(a) Results of the studies included in the ﬁnal review.
Reference Year
AHI/RDI (/h) Lowest oxygen saturation (%)
Posterior airway space
dimension
Pre-op Post-op Pre-op Post-op Pre-op Post-op
Adult group
Jihua et al[85] 2012 43.0 3.4 67.0 92.9 N.A. Markedly
increased
Feiyun et al[96] 2010 47.3 2.1 75.4 98.2 N.A. N.A
Wang et al[64] 2003 58.0 3.2 77 90.3 4.6mm
(cephalome-
try)
12.5mm
(cephalome-
try)
Children group
Rachmiel et al[84] 2012 >10 <3 85 93 N.A. Markedly
increased
Hammoudeh
et al[79]
2012 N.A. (resp.
failure
group) 39.7
(resp. dis-
tress group)
3.13 (resp.
failure
group) 5.8
(resp. dis-
tress group)
N.A. (resp.
failure
group) 86.9
(resp. dis-
tress group)
88.9 (resp.
failure
group) 89.8
(resp. dis-
tress group)
N.A. N.A.
Genecov et al[95] 2009 35–50 5–15 N.A. N.A. N.A. N.A.
Looby et al[72] 2009 10.6 2.2 83 90 41.6mm2
(retroglossal
area, CT)
127.8mm2
(retroglossal
area, CT)
Miller et al[75] 2007 19.2 1.5 N.A. N.A. N.A. N.A.
Mitsukawa
et al[100]
2007 12.6 1.5 93.4 99.2 N.A. N.A.
Rachmiel
et al[101]
2005 21.3 1.8 79.5 96.1 N.A. N.A.
Murage et al[45] 2013 37.8 6.5 N.A. N.A. N.A. N.A.
Burstein and
Williams[124]
2005 15.3 1.1 73.5 94.3 N.A. N.A.
(b)
Reference Year
Success
criteria
Success
(%)
Cure
(%)
Tracheostomy Decannulation
(%)
Complication
(%) Complications
Adult group
Jihua et al[85] 2012 N.A. 100 91.7 1 100 25 Submental
hematoma,
persistent chin
numbness
Feiyun et al[96] 2010 AHI<5 Lowest SpO2>86% 100 100 0 N.A. 0 N.A.
Wang et al[64] 2003 Disappearance of OSA,
symptoms,
AHI<5, lowest
SpO2>85%
100 82.1 0 N.A. 21.4 Temporary
lower lip
numbness
Children group
Rachmiel et al[84] 2012 N.A. N.A. N.A. 10 100 N.A. N.A.
Hammoudeh et al[79] 2012 N.A N.A. N.A. 9 100 17.2 Mechanical failure
of distractors,
transient facial
nerve palsy,
wound infection,
death in
1 patient with
multiple
medical
problems
Genecov et al[95] 2009 Decannulation
for 1 y after
distraction,
avoidance of
tracheostomy
94 N.A. 41 92 10.2 Mechanical
failure of
distractors,
wound infection,
transient facial
nerve palsy
(continued )
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Table 3
(continued).
(b)
Reference Year
Success
criteria
Success
(%)
Cure
(%)
Tracheostomy Decannulation
(%)
Complication
(%) Complications
Looby et al[72] 2009 N.A. N.A. N.A. 1 94 (avoided
tracheostomy
11.8 Wound infection,
transient facial
nerve palsy
Miller et al[75] 2007 N.A. N.A. N.A. 0 N.A. 8.3 Transient facial
nerve palsy
Mitsukawa et al[100] 2007 N.A. N.A. N.A. 2 100 N.A. N.A.
Rachmiel et al[101] 2005 N.A. N.A. N.A. 0 N.A. 0 N.A.
Murage et al[45] 2013 Avoidance of
tracheostomy
92 N.A. 4 0 N.A. N.A.
Burstein and Williams[124] 2005 Avoidance of
tracheostomy,
decannulation
90 N.A. 6 66.7 20 Wound infection
AHI= apnea–hypopnea index, CT= computed tomography, N.A.=not available, OSA= obstructive sleep apnea, RDI= respiratory disturbance index, resp.= respiratory.
Tsui et al. Medicine (2016) 95:36 MedicineThe lowest oxygen saturation (SpO2) in the adult group
improved from the range 67% to 77% preoperatively to the
range from 90.3% to 98.2% postoperatively, while in the
children group it improved from the range of 73.5% to 93.4%
preoperatively to the range from 88.9% to 99.2% postopera-
tively. Li et al[85] and Rachmiel et al[87] both reported signiﬁcant
increase in the PAS dimension based on cephalometric measure-
ments in the adult and children groups, respectively. Wang
et al[64] reported a mean increase of PAS from 4.6 to 12.5mm
after MDO in the adult group. Looby et al[77] showed a mean
increase of 209% in retroglossal area from 41.5 to 127.8mm2 in
the children group. Rachmiel et al[101] in another study
demonstrated a 71.9% increase in airway volume based on 3-
dimensional CT measurement in a group of child patients.3.6. Adjunctive procedures
Other adjunctive procedures besides MDO were reported in 4
studies. Feiyun et al[96] and Wang et al[64] reported the
simultaneous use of transport distraction for the shortened
ramus at the same time for their group of adult patients with TMJ
ankylosis. Mitsukawa et al[100] performed bilateral coronoidec-
tomies for their group of syndromic children to allow smooth
distraction process. Li et al[85] performed gap arthroplasty as well
as advancement genioplasty for their group of adults with
bilateral TMJ ankylosis. The amount of chin advancement was
12.5±2.2mm.3.7. Other functional outcomes
Surgical relapse of mandibular advancement was seldom
mentioned in the literature. Wang et al[64] and Burstein and
Williams[124] reported no clinical relapse in their group of adult
and children patients, respectively. Three studies reported the
hyoid bone advancement ranging from 1 to 10mm after
mandibular distraction in the child patients.[87,100,101] Li
et al[85] and Feiyun et al[96] demonstrated signiﬁcant improve-
ment of mouth opening from 3.3 to 4.6mm preoperatively to
36.8 to 37.6mm postoperatively in the adult patients. Genecov
et al[95] reported that MDO successfully prevented gastroesoph-
ageal and laryngeal reﬂux in children. No studies mentioned any
quality of life or psychological outcomes in MDO for OSA.103.8. Complications
The complication rate reported in the literature ranged from 0%
to 25% and 0% to 20% in the adult and children groups,
respectively. The commonly reported complications in both adult
and children groups include local wound infections around the
distractor exits, transient facial nerves palsy, numbness at the
lower lip and chin regions, anterior open bite postdistraction, and
distractor mechanical failure. Other reported complications are
requirement of postoperative tracheostomy for a child due to
coexisting medical conditions, and death of a child patient with
multiple medical problems.
4. Discussion
MMAhas been shown to be a highly effective treatment modality
for patients with OSAS. The maxillary advancement is usually
carried out by a Le-Fort I (LF-I) osteotomy, and the mandibular
advancement could be achieved by traditional sagittal split
osteotomy or distraction osteogenesis. While the effectiveness of
MMA by traditional means has been studied extensively and has
been proven in 2 systematic reviews recently,[20,138] the evidence-
based data on MDO is relatively weak. A well designed
systematic review could minimize bias and provide reliable
ﬁndings so that conclusions could be drawn and decisions could
be made on a clinical question of concern.[139] The Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) statement[38] published in 2009 has assisted inves-
tigators in developing a well structured systematic review. This
not only helps to identify the current best knowledge but also
gives insight on how further research should be directed to.
Like many other aspects in the ﬁeld of oral and maxillofacial
surgery, randomized controlled trials are difﬁcult to be carried
out. In addition, there is currently no randomized controlled trial
comparingMDOwith traditional sagittal split osteotomy or with
mandibular advancement splint therapy. There were only 7
prospective studies on MDO for OSA patients but they were
poorly reported and excluded in the selection process in this
review.[46,66,110,123,126,132] There was also no systematic review
or meta-analysis on the effect of MDO for improvement in
patients with OSA. There is clearly a research gap in the clinical
effectiveness of MDO for the treatment of OSA. We managed to
gather 12 retrospective studies regarding this aspect in the ﬁnal
[151]
Tsui et al. Medicine (2016) 95:36 www.md-journal.comround for further analysis and tried to generate the best evidence
available in the literature. This systematic review showed that
success rate of MDO in OSA patients is 90% to 100%. This is
comparable to that of traditional orthognathic surgery for
advancement of mandible in OSA patients, which has been
showed to have a success rate of 86% in a recent systematic
review.[20]
There have been numerous studies in the 1980s showing the
improvements of OSA in adult patients treated by mandibular
osteotomy for advancement,[140–142] and the trend has been
shifted from mandibular surgery alone toward the use of
combinedMMA surgery.[143,144] It has been shown in endoscopy
studies that 57% to 72% of obstruction occurred in multiple sites
from retropalatal region to tongue base level.[145,146] Other
studies also show that there are multiple oropharyngeal
abnormalities in OSA patients, and the collapse pattern of their
airways is mainly in lateral dimension.[147,148] Advancing the
mandible forward alone could only partly solve the problem of
obstruction. On the other hand, MMA could improve the
oropharyngeal obstruction in the anteroposterior as well as the
lateral dimensions of the whole upper airway[17,149] by
expanding the bimaxillary skeletal framework, resulting in the
tightening of the pharyngeal soft tissue and advancement of the
tongue position.[150] MMA could also address the concomitant
bimaxillary deﬁciency which is a common clinical ﬁnding in OSA
patients.[143,144] It also allows the maintenance of interocclusal
relationship after the surgery, which is a very important aspect
especially in adult patients in terms of functions and aesthetics.
In MMA surgery, maxillary advancement is mainly achieved
by LF-I osteotomy, while mandibular advancement could be
achieved by bilateral sagittal split osteotomies (BSSO) or bilateral
mandibular distraction osteogenesis (BMDO). This combination
represents the most straightforward way of a MMA surgery. The
choice of using BSSO or BMDO is usually based on a
combination of surgeon’s preference, amount of mandibular
movement and patient’s opinion, and is decided on a case-by-case
basis. Surgeons may have particular preference on using either
method based on their experiences and expertise as well as the
instruments’ availability in their center. The amount of
mandibular advancement also inﬂuences the choices between
BSSO and BMDO as there is anatomical limitation for the
possible advancement that BSSO could achieve and, in case when
exceptional advancement is required, BMDO may become the
only option as the amount of movement achievable is literally
unlimited. The cost of BMDO is undoubtedly higher than that of
BSSO due to the cost of the distractors, and this could be a burden
for patients with ﬁnancial difﬁculties. The need for a second
operation for the removal of distractors in BMDO is also a
negative factor for patients during the decision process between
BSSO and BMDO.
Modiﬁcation with segmentalization in LF-I osteotomy is
sometimes needed depending on the occlusal requirement and the
facial proﬁle of the patient. Segmentalized LF-I could correct the
arch form discrepancy in the transverse dimension in patients
with a narrow upper arch by allowing expansion at both anterior
and posterior aspects. Segmentalizations also help in situations
when there is dentoalveolar protrusion or in patient who are
already having a convex facial proﬁle. By extracting the ﬁrst
premolars on both sides of the upper arch, the anterior maxillary
segment could be retracted and/or uprighted. This allows
maximal maxillary advancement without compromising the
dentofacial proﬁle and aesthetics as well as maintaining a good
occlusal relationship. The safety of performing LF-I with multiple11segmentalizations is excellent when meticulous surgical
techniques are applied and the surgical anatomy are well
respected during the operation.[152] Adjunctive procedures such
as mandibular anterior subapical osteotomy (Hofer) and
advancement genioplasty could be incorporated into MMA
surgery to allow further advancement of the mandible when
maximum amount of advancement is deemed to be required.
Hofer is performed to upright and setback the anterior
dentoalveolar segment with the extraction of a premolar on
each side or through the preexisting space distal to the canine
tooth.[153] This procedure allows modiﬁcation of the arch form
and increases the amount of dental overjet. A much more
signiﬁcant mandibular advancement of the mandible could be
attained by BSSO or BMDO without compromising a normal
occlusion.[154] Advancement genioplasty could move the chin
forward to up to around 10mm depending on the bicortical
thickness of the chin segment. This movement could further help
with the MMA by pulling the tongue muscle forward and
reducing the obstruction of the airway. The facial proﬁle could be
improved from a convex to straighter proﬁle. Preexisting facial
asymmetry which becomes more obvious after the mandibular
could be corrected as well.
In this systematic review, only 7 studies mentioned about
surgical complications in brief. Facial paresthesia and neurosen-
sory disturbance in terms of chin and lip numbness, mechanical
failure of the distractors, and wound infections around the
distractors are the main complications described. The complica-
tion rate for these minor complication is 25%, which is much
higher than the rate for MMA surgery with BSSO as reported by
Holty and Guilleminault.[20] The main reason for this increased
complication rate in this group of patient with BMDO is the
presence of infection around distractor wounds and distractor
failures. Mechanical failures could be dealt with by improvement
of the distractor designs and manufacturing and careful
manipulation of distractors as well as improved ﬁxation, while
wound infection could be reduced by meticulous wound
cleansing by patients or caretakers.
There are many different designs of distractors available. They
could be grouped as external or internal devices, as well as single
vector or multivector devices. Until now, there is still no literature
comparing the effectiveness of external and external devices. No
consensus on whether external or internal distractors are better
option for MDO and they were mostly chosen based on patients’
ages and physical sizes, surgeons’ preferences, or the availability
of instrumentations. Rachmiel et al supported the use of external
distractors and claimed that they were better than the internal
counterparts in terms of better anchorage of devices, better
control of distraction, achievability of longer distraction distance,
and easy removal of distractors.[84] On the contrary, Genecov
et al[95] supported the use of internal devices as they produce
minimal scarring and allow easier breastfeeding in infants. In
practice, internal devices are seldom placed totally intraorally,
especially in infants, young children, or in patients with very
severe retrognathia. Instead, the distractor bodies were ﬁxed on
the mandible after the osteotomies through a combination of
intraoral and extraoral approaches, with the distractor rods
exiting through the skin extraorally to allow better orientation of
devices and easier activation. The major drawback of internal
distractors is the need for a second operation to remove the
distractors after the consolidation period. Most centers utilized
single vector distractors in their patients but postdistraction
anterior open bite was reported to be a common ﬁnding in some
cases. Therefore, some surgeons advocated the curvilinear devices
Tsui et al. Medicine (2016) 95:36 Medicinewhich could allow lengthening of the mandibular ramus and
body at the same time to avoid the occurrence of postdistraction
anterior open bite.[75] Elastics also help to suspend the condyle,
reducing the strain on it during active distraction and therefore
may reduce the amount of discomfort experienced by patients
during the activation period.
Most studies in the literature on patients with OSAS treated by
MDO were performed in pediatric population, and a large
proportion of them were patients having craniofacial syndromes
or deformities. There are several reasons to account for this
situation. Traditional orthognathic surgery was seldom per-
formed in pediatric patients due to the presence of developing
tooth germs or continual growth of the facial skeletons; therefore,
MMA by means of orthognathic surgery was not usually carried
out in this group of patients. MDO would be the only option to
lengthen the mandible in this group of patients in order to open
up the airway. Furthermore, pediatric patients requiring surgical
intervention for OSAS are those with severe respiratory distress
and may be on tracheostomy due to the severe airway
obstruction. Large magnitude of mandibular advancement is
usually needed, and only MDO can achieve the large advance-
ment beyond the capability of conventional orthognathic surgical
procedures. This study showed that large advancement with
MDO has resulted in signiﬁcant improvements in AHI and
oxygen saturation and subsequently allowed decannulation of
those tracheostomy-dependent children, which in turn reduced
the chances of having the morbidities with tracheostomy
including chronic bronchitis, laryngomalacia and laryngeal
stenosis, and so on.[155] With the help of PSG, MDO allows
titration of the amount of mandibular lengthening during the
active distraction period. Distraction can be continued until a
favorable AHI is achieved. Overcorrection during MDO was
suggested by in 6 studies in the review. This is especially the case
in child patients as larger mandibular advancement could allow
greater relief of the compromised airways, and as the children
grow the maxilla is going to catch up with the mandible and
achieve the correct occlusion with or without the help or the
orthodontists. However, overcorrection in adult patients have to
be dealt with carefully as there is no more growth of the maxilla
and the maintenance of occlusion is important for aesthetic and
functional requirement.
Despite the extensive study of OSAS in pediatric patients, the
criteria for deﬁning the severity of condition and treatment
success and failure are not clear. There are no standard criteria to
grade the severity of OSAS and treatment success for the children
patients. From this systematic review, we noted the need to
develop these criteria so as to help clinicians and researchers in
improving the quality of treatment for OSAS.5. Conclusion
This systematic review showed thatMDOwas highly effective in
resolving OSAS in both children and adults with retrognathic
mandible. It was found to be an invaluable means in alleviating
airway obstructions in children inwhich traditional orthognathic
surgery was deemed impossible. It could also help to avoid
tracheostomy or help to decannulation in the children/infants
population. It was also showed there were no consensus for
the criteria of success/cure for OSAS surgeries in children and
infants, and is therefore recommended for their development.
There were also no randomized controlled trials to compare
MDO and conventional orthognathic surgery to treat patients
with OSAS.12References
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